跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SUBOXONE 12 MG/3 MG PELICULA SUBLINGUAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
SUBOXONE 12 MG/3 MG PELICULA SUBLINGUAL
Approved
STANDARD
SUBOXONE 12 MG/3 MG PELICULA SUBLINGUAL
Indivior Europe Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Oct 29, 2020
Approval ID
f895a6de90c668c7
Company
Indivior Europe Limited
Type
Standard
Approval Details
Approval Id
f895a6de90c668c7
Drug Cima Aemps Name
SUBOXONE 12 MG/3 MG PELICULA SUBLINGUAL
Register Number
106359016
Holder Company Name
Indivior Europe Limited
Marketing Company Name
Indivior Europe Limited
Holder Company Detail Path
/organization/indivior-europe-ltd
Marketing Company Detail Path
/organization/indivior-europe-ltd
Authorization Date
2020-10-29
Dosage Form
PELICULA SUBLINGUAL
Dose
12 mg/3 mg
Route Of Administration
Vía bucal (buccal use), VÍA SUBLINGUAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Indivior Europe Limited
Company Detail Path
/organization/indivior-europe-ltd
Company Information
Pharmaceutical Company Name
Indivior Europe Limited
Name En
Indivior Europe Limited
Country Name
Ireland
Active Ingredients
BUPRENORFINA HIDROCLORURO
12,96 mg
NALOXONA HIDROCLORURO DIHIDRATO
3,66 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Oct 29, 2020
Approval ID
f895a6de90c668c7
Type
Standard
Back to CIMA-AEMPS Approvals